No Record Found
Sector
PharmaceuticalsOpen
₹1,518Prev. Close
₹1,511Turnover(Lac.)
₹1,221.75Day's High
₹1,600Day's Low
₹1,51152 Week's High
₹1,627.752 Week's Low
₹535Book Value
₹148.58Face Value
₹10Mkt Cap (₹ Cr.)
4,777.7P/E
233EPS
6.76Divi. Yield
0.06No Record Found
| Y/e 31 Mar( In .Cr) | Mar-2025 | Mar-2024 | Mar-2023 | Mar-2022 | 
|---|---|---|---|---|
Equity Capital  | 28.64  | 25.85  | 25.16  | 25.16  | 
Preference Capital  | 0  | 0  | 0  | 0  | 
Reserves  | 288.73  | 95.93  | 69.3  | 66.21  | 
Net Worth  | 317.37  | 121.78  | 94.46  | 91.37  | 
Minority Interest  | 
| Y/e 31 Mar( In .Cr) | Mar-2021 | Mar-2020 | Mar-2019 | Mar-2018 | 
|---|---|---|---|---|
Revenue  | 106.84  | 95.08  | 85.62  | 77.84  | 
yoy growth (%)  | 12.36  | 11.03  | 10  | 8.75  | 
Raw materials  | -73.34  | -66.3  | -57.01  | -51.03  | 
As % of sales  | 68.64  | 69.72  | 66.58  | 65.56  | 
Employee costs  | -9.3  | -10.34  | -8.89  | -6.63  | 
| Y/e 31 Mar( In .Cr) | Mar-2021 | Mar-2020 | Mar-2019 | Mar-2018 | 
|---|---|---|---|---|
Profit before tax  | -1.34  | 3.88  | 7.85  | 11.36  | 
Depreciation  | -3.16  | -2.09  | -1.39  | -0.93  | 
Tax paid  | 0.15  | -1.12  | -2.3  | -4.07  | 
Working capital  | 2.77  | -2.38  | 8.18  | 12.04  | 
Other operating items  | 
| Y/e 31 Mar | Mar-2021 | Mar-2020 | Mar-2019 | Mar-2018 | 
|---|---|---|---|---|
Growth matrix (%)  | ||||
Revenue growth  | 12.36  | 11.03  | 10  | 8.75  | 
Op profit growth  | -85.09  | -41.46  | -28.94  | 8.56  | 
EBIT growth  | -131.25  | -49.98  | -31.23  | 26.97  | 
Net profit growth  | -105.88  | -50.28  | -23.6  | 31.15  | 
| Particulars (Rupees in Crores.) | Mar-2025 | Mar-2024 | Mar-2023 | Mar-2022 | Mar-2021 | 
|---|---|---|---|---|---|
Gross Sales  | 292.97  | 180.49  | 139.96  | 131.19  | 106.79  | 
Excise Duty  | 0  | 0  | 0  | 0  | 0  | 
Net Sales  | 292.97  | 180.49  | 139.96  | 131.19  | 106.79  | 
Other Operating Income  | 0  | 0  | 0  | 0  | 0  | 
Other Income  | 2.07  | 1.16  | 2.49  | 1.63  | 2.29  | 
Company Name  | LTP (₹)  | P/E  (%)  | Mkt.Cap  (₹Cr.)  | NP Qtr (₹Cr.)  | Div.Yield  (%)  | Sales Qtr  (₹.Cr)  | Book Value (₹)  | 
|---|---|---|---|---|---|---|---|
Sun Pharmaceutical Industries Ltd SUNPHARMA  | 1,706.4  | 82.24 | 4,09,626.46 | 753.53 | 0.94 | 5,566.68 | 101.44 | 
Divis Laboratories Ltd DIVISLAB  | 6,804  | 77.34 | 1,80,668.62 | 557 | 0.44 | 2,357 | 561.08 | 
Torrent Pharmaceuticals Ltd TORNTPHARM  | 3,628.3  | 61.77 | 1,22,787.57 | 551 | 0.17 | 2,567 | 224.34 | 
Cipla Ltd CIPLA  | 1,511.5  | 23.49 | 1,22,102.7 | 1,210.53 | 1.06 | 4,495.16 | 411.56 | 
Dr Reddys Laboratories Ltd DRREDDY  | 1,196  | 18.5 | 99,857.36 | 387.3 | 0.67 | 4,602.9 | 377.57 | 
Figures of Market Capital(Mar Cap), Quarterly Net Profit(NP Qtr) and Quarterly Sales(Sales Qtr) are in ₹ Cr.
Chairman & Non Executive Director
Ketankumar Zota
Managing Director
Moxesh Zota
Whole-time Director
Kamlesh Zota
Whole-time Director
Himanshu Zota
Whole-time Director
Manukant Zota
Independent Director
Varsaben Mehta
Company Secretary
Ashvin Variya
Additional Independent Director
Bhumi Maulik Doshi
Independent Director
Dhiren Prafulbhai Shah
Independent Director
Jayshreeben N Mehta
Zota House 2/896 Hira Modi St,
Sagrampura,
Gujarat - 395002
Tel: 91-261-2331601
Website: http://www.zotahealthcare.com
Email: info@zotahealthcare.com
Unit-49 Bldg-13 AB,
Off Andheri Kurla Rd, MTNL Lane Sakinaka,
Mumbai-400072
Tel: 91-22-28520461
Website: www.satellitecorporate.com
Email: service@satellitecorporate.com
Summary
Zota Health Care Limited is a renowned pharmaceutical company that manufactures, markets, and exports pharmaceutical, ayurvedic, nutraceutical, and over-the-counter (OTC) products. The Company was inc...
Read More
Reports by Zota Health Care Ltd
 IIFL Customer Care Number 
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000  / 7039-050-000
 IIFL Capital Services Support WhatsApp Number
+91 9892691696
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248, DP SEBI Reg. No. IN-DP-185-2016, BSE Enlistment Number (RA): 5016
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor)

This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.